Literature DB >> 20577087

Distinct dacryoadenitides autoadoptively transferred to rabbits by different subpopulations of lymphocytes activated ex vivo.

Padmaja B Thomas1, Deedar M Samant, Yanru Wang, Shivaram Selvam, Douglas Stevenson, John D Gray, Joel E Schechter, Austin K Mircheff, Melvin D Trousdale.   

Abstract

PURPOSE: To test whether CD4+ T cells proliferate in mixed cell reactions with autologous lacrimal gland (LG) acinar cells and whether these cells can autoadoptively transfer disease.
METHODS: Purified acinar cells were gamma irradiated and cocultured with peripheral blood lymphocytes. Activated CD4+ T cells were sorted by fluorescence-activated cell sorting (FACS). Unfractionated activated peripheral blood lymphocytes (UF), CD4+-enriched and CD4+-depleted T cells from an autologous mixed cell reaction were injected into the donor rabbit's remaining LG. After 4 weeks, ocular examinations were performed, and the rabbits were euthanized; LGs were removed for histopathology, immunohistochemistry, and real-time reverse transcription-polymerase chain reaction studies.
RESULTS: CD4 T cells increased in the autologous mixed cell reaction from 20% to 80%. Tear production decreased in the induced disease/UF (ID/UF) group and declined even more in the ID/CD4+-enriched group. Tear breakup times decreased and rose bengal staining increased in all groups. All LGs exhibited significant histopathology and increased messenger RNAs for tumor necrosis factor α. The ID/UF group exhibited the largest increases of CD4+ and rabbit T-lymphocyte antigen-positive cells. The ID/CD4+-enriched group contained fewer infiltrating CD4 cells but more eosinophils, severely altered acinar morphology, and increased fibrosis. LG of the ID/CD4+-depleted group exhibited large increases of CD18, major histocompatibility complex II, and CD4+ cells. Messenger RNAs for interleukin 2, interleukin 4, and CD4+ increased in the ID/CD4+-enriched group compared with the CD4+-depleted group.
CONCLUSIONS: Autoreactive CD4+ effector cells activated ex vivo and autoadoptively transferred, caused what seems to be a distinct dacryoadenitis. The CD4+-depleted cell fraction also contained pathogenic effector cells capable of inducing disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20577087      PMCID: PMC2945426          DOI: 10.1097/ICO.0b013e3181d0090e

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  28 in total

1.  Lacrimal gland epithelial cells stimulate proliferation in autologous lymphocyte preparations.

Authors:  Z Guo; A M Azzarolo; J E Schechter; D W Warren; R L Wood; A K Mircheff; H R Kaslow
Journal:  Exp Eye Res       Date:  2000-07       Impact factor: 3.467

2.  Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.

Authors:  Malin V Jonsson; Nicolas Delaleu; Karl A Brokstad; Ellen Berggreen; Kathrine Skarstein
Journal:  Arthritis Rheum       Date:  2006-07

Review 3.  Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease.

Authors:  Cuong Q Nguyen; Ammon B Peck
Journal:  Ocul Surf       Date:  2009-01       Impact factor: 5.033

4.  Expression of IL-10 and TNF-inhibitor genes in lacrimal gland epithelial cells suppresses their ability to activate lymphocytes.

Authors:  Zejin Zhu; Douglas Stevenson; Thomas Ritter; Joel E Schechter; Austin K Mircheff; Harvey R Kaslow; Melvin D Trousdale
Journal:  Cornea       Date:  2002-03       Impact factor: 2.651

5.  Effects of age on morphology, protein synthesis and secretagogue-evoked secretory responses in the rat lacrimal gland.

Authors:  Clare E Draper; Jaipaul Singh; Ernest Adeghate
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

6.  Autoimmune dacryoadenitis and keratoconjunctivitis induced in rabbits by subcutaneous injection of autologous lymphocytes activated ex vivo against lacrimal antigens.

Authors:  P B Thomas; Z Zhu; S Selvam; D M Samant; D Stevenson; A K Mircheff; J E Schechter; S W Song; M D Trousdale
Journal:  J Autoimmun       Date:  2008-06-04       Impact factor: 7.094

7.  T and B cell recovery in arthritis adoptively transferred to SCID mice: antigen-specific activation is required for restoration of autopathogenic CD4+ Th1 cells in a syngeneic system.

Authors:  Tamás Bárdos; Katalin Mikecz; Alison Finnegan; Jian Zhang; Tibor T Glant
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

8.  Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging.

Authors:  H Obata; S Yamamoto; H Horiuchi; R Machinami
Journal:  Ophthalmology       Date:  1995-04       Impact factor: 12.079

9.  Suppression of lymphocyte proliferation and regulation of dendritic cell phenotype by soluble mediators from rat lacrimal epithelial cells.

Authors:  M de Saint Jean; T Nakamura; Y Wang; M D Trousdale; J E Schechter; A K Mircheff
Journal:  Scand J Immunol       Date:  2009-07       Impact factor: 3.487

10.  Expression of TNF inhibitor gene in the lacrimal gland promotes recovery of tear production and tear stability and reduced immunopathology in rabbits with induced autoimmune dacryoadenitis.

Authors:  Melvin D Trousdale; Zenjin Zhu; Douglas Stevenson; Joel E Schechter; Thomas Ritter; Austin K Mircheff
Journal:  J Autoimmune Dis       Date:  2005-06-28
View more
  2 in total

1.  Multiple Natural and Experimental Inflammatory Rabbit Lacrimal Gland Phenotypes.

Authors:  Austin K Mircheff; Yanru Wang; Joel E Schechter; Meng Li; Warren Tong; Mayssa Attar; Murty Chengalvala; Joe Harmuth; Jeffery J Prusakiewicz
Journal:  Ocul Surf       Date:  2016-07-15       Impact factor: 5.033

2.  Adipose-Derived Mesenchymal Stem Cells Reduce Lymphocytic Infiltration in a Rabbit Model of Induced Autoimmune Dacryoadenitis.

Authors:  Xue Li; Xiaoxiao Lu; Deming Sun; Xilian Wang; Liyuan Yang; Shaozhen Zhao; Hong Nian; Ruihua Wei
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-10-01       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.